Macular Degeneration

Offers information on macular degeneration, or AMD, and also how to stop age related macular degeneration.

Entries Tagged ‘amd’

Macular Degeneration Treatment

Treating Macular Degeneration
There are two treatable types of age related macular degeneration. The most common type is called age related macular degeneration or AMD.  The second type is called wet macular degeneration, and it comprises a much smaller percentage of the cases.  Since wet macular degeneration involves the formation of new blood [...]

Dry Macular Degeneration or Wet Macular Degeneration?

Dry Macular Degeneration or Wet Macular Degeneration?
What is the difference?
Learn how to stop macular degeneration.
Macular degeneration is a disease that afflicts millions of Americans.  Macular Degeneration comes in a number of forms.  The genetic forms are the worst forms because the onset of the disease begins in youth or in the first couple of decades [...]

What Is Macular Degeneration

Macular Degeneration:
Causes, Prevention, & Treatment

Looking for Macular Degeneration Treatment?  Then click here now.

The human eye is a very complex and highly evolved organ.  Humans are able to see when light rays enter the eye through the pupil.  These light rays are received by sophisticated nerves on the surface of the back of the eye [...]

Implantation of blue light-filtering intraocular lens increases nutritional component of the eye

Results of an important new study show that implantation of blue light-filtering intraocular lens (IOLs) at the time of cataract surgery increases a nutritional component of the eye, which may afford protection against the development and/or progression of age-related macular degeneration (AMD).

Potentia Pharmaceuticals Enters into Licensing and Purchase Option Agreements with Alcon

LOUISVILLE, Kentucky – – Alcon takes over development of POT-4 as a treatment for patients with age-related macular degeneration – Deal provides path for Alcon to acquire Potentia Potentia Pharmaceuticals, a privately-held biotechnology company developing medicines for the treatment of age-related macular degeneration (AMD), announced today that it has entered into licensing and purchase option agreements with [...]